- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05235958
VascuFit: Exercise and Vascular Aging (VascuFit)
Vascular Effects of Non-linear Periodized Exercise Training in Sedentary Adults With Elevated Cardiovascular Risk - The VascuFit Project
Exercise is a cornerstone of health care helping to improve and maintain a good organ functionality, including vascular function, in health and disease. About twenty years ago, the introduction of high-intensity training has been a milestone in the evolution of exercise therapy by demonstrating the trainability of individuals independent of age and state of disease. Today, its practical implementation still faces barriers, such as lower physical and mental tolerance of exercise, long-term adherence and lack of individualization of training for optimal adaptations.
The proposed project is the logical next step to introduce non-linear periodized exercise training (NLPE), a method widely established in elite athletes, in exercise training of sedentary individuals. NLPE alternatingly involves person-centred periodization of training cycles and regeneration with high-intensity stimuli. It induces a broader range of physiological adaptations than moderate-intensity training while keeping a high compliance and without increasing the risk of overreaching. A study of patients with chronic-obstructive-pulmonary-disease and a study with resistance training of older adults indicated promising pulmonary and muscular effects. However, the effectiveness of NLPE to maintain and improve vascular function has not yet been assessed, although this may carry a huge clinical and socioeconomic potential by contributing to the reduction of cardiovascular morbidity and mortality.
VascuFit applies an 8-week training intervention to assess the effects of NLPE on the function of the vascular endothelium, measured by the non-invasive gold-standard method brachial arterial flow-mediated dilation (baFMD), in a sample of sedentary aging adults with cardiovascular risk factors. In addition, it will be the first study to measure training effects on a cluster of micro-ribonucleic acids (miRNAs) regulating key molecular pathways of endothelial (dys-)function. Thus, VascuFit aims to explore the potential of clinical and molecular biomarkers for the monitoring of individual vascular adaptability to a specific type of exercise. As a first step, this pilot-project is supposed to deliver proof-of-concept. Furthermore, it will generate important hypotheses to be addressed by exercise physiologists, medical professionals and biologists concerned with the optimization of individual training adaptations as well as utility and implementation of targeted training approaches in the health care of aging adults.
VascuFit aims to demonstrate the potential of NLPE as a training regimen to improve vascular function in sedentary individuals with elevated cardiovascular risk. This project may be the initial spark to raise exercise training to the next level, which is clearly necessary to sustainably strengthen the vascular capacities of "young" aging individuals.
Study Overview
Status
Intervention / Treatment
Detailed Description
A detailed description of the study can be found at:
DOI: 10.1186/s12872-022-02905-1
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Basel, Switzerland, 4052
- Departement of Sport, Exercise and Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Informed consent, documented by signature
- sedentary lifestyle, as not performing exercise on a regular basis and reaching less than the recommended 7.5 MET hours of at least moderate intensity activity per week
- being mentally and physically able to attend and keep up training during the whole intervention period.
Exclusion Criteria:
- current or chronic condition limiting exhaustive exercise (e.g. heart failure, infection, pulmonary disease)
- any condition with elevated risk of a serious adverse event during exhaustive exercise (e.g. cardiomyopathy, acute myocardial infarction, stroke, uncontrolled hypertensive resting blood pressure ≥160/100mmHg)
- chronic condition with severe affection of the vascular system (e.g. severe atherosclerosis, severe chronic kidney disease, autoimmune vasculitis, insulin dependent diabetes mellitus)
- inability to follow advice during measurements and training sessions (e.g. language barriers, psychological disorders, dementia)
- previous enrollment into the current study or participation in another study in the last four weeks.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Training intervention
8 weeks of non-linear periodized aerobic exercise; 3 sessions per week; 1 hour per session; standardized warm-up; individual training intensity according to cardiorespiratory fitness level
|
Aerobic training derived from professional sports, that is characterized by variable periodization of training frequency, volume and intensity according to individual factors, such as physical and mental readiness, training progress and performance level
|
|
Sham Comparator: Control Intervention
Recommendation to continue with current lifestyle (especially physical activity habits) during the following 8 weeks.
At the final assessment after 8 weeks, individualized exercise recommendations according to established standard procedures in exercise medicine and offer to attend the standard medical follow-up in our outpatient clinics subsequent to study termination
|
Standard recommendations for exercise and physical activity, that are individualized according to a medical health and fitness profile
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Brachial-arterial flow-mediated vasodilation (baFMD)
Time Frame: 8 weeks
|
Non-invasive ultrasound-based measurement of endothelial responsiveness of the brachial artery to an hyperemic stimulus.
Changes of baFMD after the 8-week study period in comparison to the pre-intervention baseline values will be assessed.
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
endomiR
Time Frame: 8 weeks
|
Quantification of several micro-RNAs involved in key-regulatory pathways of the endothelial function of the macrovascular circulation.
Changes of this micro-RNA cluster (endomiR) after the 8-week study period in comparison to the pre-intervention baseline values will be assessed.
|
8 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Static retinal vessel analysis (SVA)
Time Frame: 8 weeks
|
Non-invasive ultrasound-based measurement of endothelial responsiveness of the retinal arterioles and venules.
Changes of SVA after the 8-week study period in comparison to the pre-intervention baseline values will be assessed.
|
8 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Karsten Königstein, Dr. med., University of Basel
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- VF_CTgov
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aerobic Exercise
-
Holy Name Medical Center, Inc.Not yet recruiting
-
Hasan Kalyoncu UniversityNot yet recruiting
-
Afyonkarahisar Health Sciences UniversityCompleted
-
University of Dublin, Trinity CollegeCompletedAerobic Exercise
-
University Hospital MuensterGerman Federal Ministry of Education and ResearchUnknownAerobic Exercise | Anaerobic Exercise | Unchanged ConditionGermany
-
University of North Carolina, GreensboroRecruitingCognitive Change | Aerobic ExerciseUnited States
-
Ondokuz Mayıs UniversityCompletedExercise Performance | Aerobic CapacityTurkey (Türkiye)
-
Chang Gung Memorial HospitalCompleted
-
University of MilanUniversita di VeronaRecruitingAerobic Exercise | StretchingItaly
-
University of GeorgiaCompletedBiomarkers | Aerobic Exercise | Acute ExerciseUnited States
Clinical Trials on non-linear periodized exercise (NLPE)
-
Umeå UniversityRadboud University Medical Center; Centre de Recherche de l'Institut Universitaire... and other collaboratorsCompletedPulmonary Disease | Chronic ObstructiveSweden, Canada, Netherlands
-
University of LisbonCompletedCardiovascular Diseases | Coronary Artery DiseasePortugal
-
Cairo UniversityRecruitingHypothyroidismEgypt
-
University of British ColumbiaCompletedThe Effects of Aerobic Exercise Training on Vascular, Cardiac and Cerebral Vascular Function in COPDChronic Obstructive Pulmonary DiseaseCanada
-
Riphah International UniversityCompletedDiabetes Mellitus, Type 2Pakistan
-
Universidade Federal do Rio de JaneiroCompleted
-
Hasselt UniversityCompletedMultiple SclerosisBelgium
-
University College, LondonCompletedFrequency Compression | Severe-profound Hearing Impairment
-
Northwell HealthRecruitingEar Diseases | Middle Ear Disease | Pressure Injury | Eustachian Tube Dysfunction | Ear Barotrauma | Middle Ear; Injury | Middle Ear BarotraumaUnited States
-
Memorial Sloan Kettering Cancer CenterDuke UniversityCompleted